Status:
COMPLETED
Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)
Lead Sponsor:
National University of Natural Medicine
Collaborating Sponsors:
Healthy Living Community
Conditions:
Ehlers-Danlos Syndrome
Hypermobile EDS (hEDS)
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
A feasibility study of an integrative medicine program among patients with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS)
Detailed Description
The overall purpose of this study is to assess the feasibility of conducting a 9-week integrative medicine program that is comprised of a prescribed anti-inflammatory (Mediterranean) diet, as well as ...
Eligibility Criteria
Inclusion
- Age 18-65
- Beighton score of 4 or more to confirm joint hypermobility diagnosis
- Baseline VAS Score of 1 or more
- Not currently, or already a patient of Dr. Schaefer and Healthy Living Community
- Ability to provide written informed consent
- Willingness to participate in 9-week integrative medicine intervention (and make dietary and lifestyle changes)
- Willingness to attend 1 in-person screening visit and 2 virtual office visits (or 3 virtual visits, if medical documentation of Beighton score can be provided in advance of enrollment, and all other criteria are met)
- Access to an electronic device for MyFitnessPal food-tracker use (i.e mobile device, tablet, laptop)
Exclusion
- Pregnant and lactating women, or planned pregnancy over the next 3 months
- Consumption of more than 14 (men) or 7 (women) alcoholic drinks per week
- History of disordered eating or eating disorder
- Body mass index (BMI) considered underweight (\<18.5)
- Weight loss from metastatic cancer
- Unable to make dietary changes or participate in a 9-integrative medicine nutritional intervention
- Those with significant dietary changes, new medications, or new exercise routines within the past 90 days
- Currently, or already, a patient of Dr. Schaefer and Healthy Living Community
Key Trial Info
Start Date :
December 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04734041
Start Date
December 23 2020
End Date
July 2 2021
Last Update
July 15 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National University of Natural Medicine
Portland, Oregon, United States, 97201
2
Healthy Living Community
Portland, Oregon, United States, 97202